Cargando…

To study the incidence of anemia in HIV-infected children on zidovudine-based highly active antiretroviral therapy regimen

Detalles Bibliográficos
Autores principales:	Maurya, Manisha, Badrinath, Shruthi, Singh, Dharmendra K., Rai, Ruchi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529157/ https://www.ncbi.nlm.nih.gov/pubmed/33063007 http://dx.doi.org/10.4103/ijstd.IJSTD_79_17

Ejemplares similares

A case of zidovudine induced pigmentation on palms and soles
por: Singh, Satyendra Kumar, et al.
Publicado: (2014)

Zidovudine-induced myopathy
por: Wiwanitkit, Viroj
Publicado: (2011)

INCIDENCE OF ANAEMIA AMONG HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE-CONTAINING ANTIRETROVIRAL THERAPY IN NORTHEASTERN NIGERIA
por: Ikunaiye, N.Y., et al.
Publicado: (2018)

Ischemic maculopathy in zidovudine-induced anemia in an HIV-positive man
por: Yoganathan, Kathir, et al.
Publicado: (2008)

Risk Factors of Treatment-Limiting Anemia after Substitution of Zidovudine for Stavudine in HIV-Infected Adult Patients on Antiretroviral Treatment
por: Phe, Thong, et al.
Publicado: (2013)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

Correspondence - “Bone health, HIV-infected children, antiretroviral therapy, and hemoglobinopathy”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Incidence of bacteremia in antiretroviral-naive HIV-positive children less than five years of age in Benin City, Nigeria
por: Imade, Paul E., et al.
Publicado: (2010)

Anemia among HIV Infected Individuals Taking ART with and without Zidovudine at Addis Ababa, Ethiopia
por: Tamir, Zemenu, et al.
Publicado: (2018)

Zidovudine.
por: Sperling, R
Publicado: (1998)

Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries
por: Sartorius, Benn KD, et al.
Publicado: (2013)

Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
por: Mega, Teshale Ayele, et al.
Publicado: (2020)

A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India
por: Maurya, Shesh Prakash, et al.
Publicado: (2022)

Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine versus Zidovudine-Lamivudine-Efavirenz Antiretroviral Treatment (ART) Among HIV-1 Infected Children: Asella Teaching and Referral Hospital, South-East Ethiopia
por: Sorsa, Abebe
Publicado: (2018)

HIV and Anemia Among Pregnant
por: Joob, Beuy, et al.
Publicado: (2012)

Nucleoside reverse transcriptase inhibitors (zidovudine and stavudine) side-effects in people living with human immunodeficiency virus/acquired immunodeficiency syndrome attending the antiretroviral treatment center of B.J. Medical College and Civil Hospital at Ahmedabad, Gujarat, India
por: Shah, Asha N., et al.
Publicado: (2013)

Stroke as an Initial Manifestation of Thiamine-Responsive Megaloblastic Anemia
por: Madaan, Priyanka, et al.
Publicado: (2020)

Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti
por: Pierre, Samuel, et al.
Publicado: (2021)

Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand
Publicado: (2016)

Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS
por: Renner, Lorna A, et al.
Publicado: (2013)

Zidovudine Induced Hyperpigmentation
por: Premjith, Raveendran, et al.
Publicado: (2022)

Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV
por: Foster, C, et al.
Publicado: (2016)

Relationship between bortezomib-containing regimens and the incidence of tuberculosis in patients with myeloma
por: Kim, Kihyun, et al.
Publicado: (2013)

Risk adapted transmission prophylaxis to prevent vertical HIV–1 transmission: Effectiveness and safety of an abbreviated regimen of postnatal oral Zidovudine
por: Neubert, Jennifer, et al.
Publicado: (2013)

Tuberculosis Incidence and Its Predictive Factors among Patients Receiving Antiretroviral Therapy in Dilla Hospital, Ethiopia
por: BEKALO, Sapa Wolde, et al.
Publicado: (2017)

Reversible Small Vessel Vasculitis and Encephalitis in HIV Antiretroviral Resistance
por: Muir, Ryan T, et al.
Publicado: (2020)

Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer
por: Schneider, Marcel A., et al.
Publicado: (2021)

Efficacy and Tolerability of Tenofovir Disoproxil Fumarate Based Regimen as Compared to Zidovudine Based Regimens: A Systematic Review and Meta-Analysis
por: Dadi, Tegene Legese, et al.
Publicado: (2017)

Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring
por: von Wyl, Viktor, et al.
Publicado: (2012)

HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi
por: Demir, Münevver, et al.
Publicado: (2016)

Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
por: Saraceni, Valeria, et al.
Publicado: (2014)

A Case-Control Study of the MTHFR C665T Gene Polymorphism on Macrocytic Anemia Among HIV-Infected Patients Receiving Zidovudine
por: Pertiwi, Danis, et al.
Publicado: (2022)

Measuring the Efficacy of Antiretroviral Therapy
por: Gude, Dilip
Publicado: (2012)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
por: Lau, Jillian SY., et al.
Publicado: (2021)

Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go
por: Doherty, Tanya, et al.
Publicado: (2015)

Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings
por: Kiragga, Agnes N, et al.
Publicado: (2010)

Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss
por: van Vonderen, Marit G. A., et al.
Publicado: (2009)

Long-term reduction in the incidence of aplastic anemia and immune thrombocytopenia during the COVID-19 pandemic
por: Sakurai, Masatoshi, et al.
Publicado: (2023)

Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women
por: Huntington, Susie, et al.
Publicado: (2014)

Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort
por: Scarsi, Kimberly K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o5kp6fute2g796no9181ga7t44